Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Dok Hyun Yoon, Jong-Ho Won, Deok-Hwan Yang, Young-Rok Do, Won Sik Lee, Jeong-A Kim, Min Kyoung Kim, Jae-Cheol Jo, MD PhD, Youngil Koh, MD PhD

Blood (2016) 128 (22): 1823.

https://doi.org/10.1182/blood.V128.22.1823.1823

Published: 2016

Journal Articles

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Mark H. Lee, MD., PhD., Sung-Yong Kim, MD.PhD., Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Yang Soo Kim, MD.PhD., Ho Sup Lee, MD, Jeong-A Kim, MD.PhD., Jinny Park, MD.PhD., Seok Jin Kim, MD, PhD, Sung Kyu Park, MD.PhD., Byeong-Bae Park, MD.PhD., Hyeok Shim, MD.PhD., Hyeon Seok Eom, MD, Junglim Lee, MD

Blood (2012) 120 (21): 4517.

https://doi.org/10.1182/blood.V120.21.4517.4517

Published: 2012

Journal Articles

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Byeong-Bae Park, MD, Jong Gwang Kim, MD,PhD, HyeonSeok Eom, MD,PhD, Hyo Jin Kim, MD,PhD, Hyuck Chan Kwon, MD,PhD, Sung Yong Oh, MD, Jung Hun Kang, MD, Suk Joong Oh, MD,PhD, Ho-Jin Shin, MD,PhD, Cheolwon Suh, MD,PhD, Jung Han Kim, MD, Ho Young Kim, MD, Sang Cheol Lee, MD, Kihyun Kim, MD,PhD, Chul W. Jung, MD,PhD, Won Seog Kim, MD,PhD

Blood (2006) 108 (11): 4670.

https://doi.org/10.1182/blood.V108.11.4670.4670

Published: 2006

Journal Articles

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

Jeeyun Lee, MD, Won Seog Kim, MD, Sung Yong Oh, MD, Jung Mi Kwon, MD, Hyun Jung Kim, MD, Hyo-Rak Lee, MD, Byeong Bae Park, MD, Kihyun Kim, MD, Chul W. Jung, MD, Keunchil Park, MD

Blood (2005) 106 (11): 4743.

https://doi.org/10.1182/blood.V106.11.4743.4743

Published: 2005

Journal Articles

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Chul W. Jung, MD, Jeeyun Lee, MD, Byeong Bae Park, MD, Se H. Park, MD, Jung Han Kim, MD, Jung Mi Kwon, MD, Sung Yong Oh, MD, Hyun Jung Kim, MD, Hyorak Lee, MD, Kihyun Kim, MD, Jin Seok Ahn, MD, Won Seog Kim, MD, Keunchil Park, MD

Blood (2005) 106 (11): 1769.

https://doi.org/10.1182/blood.V106.11.1769.1769

Published: 2005

NARROW

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Waldeyer's Ring Marginal Zone B-Cell Lymphoma: Which Is Their Clinical and Prognostic Feature, Nodal or Extranodal?

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Email alerts

ASH Publications

American Society of Hematology

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Waldeyer's Ring Marginal Zone B-Cell Lymphoma: Which Is Their Clinical and Prognostic Feature, Nodal or Extranodal?

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only